Perspective on Pivotal Trial Designs in SLE — Lessons Learned, Monday 30 March at 1pm

Professor Vibeke Strand, Stanford University School of Medicine, will be the guest speaker at the Monash Rheumatology weekly meeting on Monday March 30 at 1 pm in the Medicine Seminar Room. 

Her topic will be:  Perspective on Pivotal Trial Designs in SLE — Lessons Learned

Vibeke is a leader in clinical research in SLE and RA and we are fortunate to have her join us. She is also keen to learn more about our programs.

Vibeke  serves a consultant in clinical research and regulatory affairs to pharmaceutical and biotech companies. She graduated from Swarthmore College with honors, attended the University of California, San Francisco School of Medicine and returned there to complete her subspecialty Rheumatology Fellowship.  She was one of eight in the first Primary Care Internal Medicine Residency at Michigan State University. She has been a clinical rheumatologist for 30 years - in subspecialty practice in San Francisco, as a clinical investigator, as an IRB member and subsequently as the director of clinical research at 3 pharmaceutical and biotech companies. She is a member of the clinical faculty at Stanford University, serving as Clinical Professor, Adjunct, Division of Immunology and Rheumatology since September 2000; Clinical Associate Professor since March 1993, and previously as Assistant and Associate Clinical Professor at University of California San Francisco (1981-1993).  Her professional interests include development of outcome measures methodology, and clinical and regulatory strategies leading to approval of new agents for treatment of autoimmune diseases, including rheumatoid arthritis [RA], osteoarthritis [OA], fibromyalgia [FMS], gout, systemic lupus erythematosus [SLE] and systemic sclerosis [SSc].